pgl-3 luciferase promoter reporter vector (Promega)
90
Structured Review
Promega
pgl-3 luciferase promoter reporter vector
Pgl 3 Luciferase Promoter Reporter Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl-3+luciferase+promoter+reporter+vector/pgl3+basic/pm28726915-81-14-20
Average 90 stars, based on 1 article reviews
Pgl 3 Luciferase Promoter Reporter Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl-3+luciferase+promoter+reporter+vector/pgl3+basic/pm28726915-81-14-20
Average 90 stars, based on 1 article reviews
pgl-3 luciferase promoter reporter vector - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Sequencing:Article Title: Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression. Article Snippet: Radiotherapy in ovarian cancer frequently invokes resistance; this severely compromises its therapeutic effect and results in poor clinical prognosis.. How to overcome the acquired resistance and re-sensitize tumors to radiation is the central question in this clinical setting.. Cancer cell survival was evaluated using a clonogenic assay. Clone Assay:Article Title: Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression. Article Snippet: Radiotherapy in ovarian cancer frequently invokes resistance; this severely compromises its therapeutic effect and results in poor clinical prognosis.. How to overcome the acquired resistance and re-sensitize tumors to radiation is the central question in this clinical setting.. Cancer cell survival was evaluated using a clonogenic assay. Luciferase:Article Title: Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression. Article Snippet: Radiotherapy in ovarian cancer frequently invokes resistance; this severely compromises its therapeutic effect and results in poor clinical prognosis.. How to overcome the acquired resistance and re-sensitize tumors to radiation is the central question in this clinical setting.. Cancer cell survival was evaluated using a clonogenic assay. Plasmid Preparation:Article Title: Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression. Article Snippet: Radiotherapy in ovarian cancer frequently invokes resistance; this severely compromises its therapeutic effect and results in poor clinical prognosis.. How to overcome the acquired resistance and re-sensitize tumors to radiation is the central question in this clinical setting.. Cancer cell survival was evaluated using a clonogenic assay. |